Skip to main content
. 1999 Jan 19;96(2):586–591. doi: 10.1073/pnas.96.2.586

Table 1.

Summary of GA, sex, CE, Mf, and smoking exposure for preterm and full-term newborns

Subject number Sex GA, weeks CE Mf × 10−6 lnMf × 10−6 95% Confidence interval
Smoking group*
Lower Upper
Preterm newborns
PI 4 F 26 0.24 1.04 0.04 −0.86 0.94 I
PI 9 F 27 0.08 4.36 1.47 0.62 2.32 I
PS 8 F 27 0.19 2.52 0.92 0.02 1.82 III
PI 31 F 29 0.01 17.41 2.86 0.08 5.63 III
PS 9 F 29 0.34 0.54 −0.61 −1.76 0.53 II
PI 22 F 30 0.12 1.45 0.37 −1.04 1.79 I
PS 25 F 30 0.06 1.16 0.15 −1.29 1.58 I
PI 25 F 31 0.11 3.17 1.15 0.14 2.17 I
PI 33 F 31 0.14 0.41 −0.88 −2.86 1.09 III
PI 41 F 31 0.16 6.54 1.88 −0.10 3.85 I
PS 26a F 31 0.53 0.66 −0.42 −1.18 0.35 I
PS 26c F 31 0.40 0.44 −0.83 −2.80 1.14 I
PI 36 F 32 0.19 0.78 −0.24 −1.40 0.91 I
MFS 28 F 33 0.03 1.93 0.66 −1.44 2.76 I
PI 3 F 33 0.10 1.74 0.55 −0.86 1.97 IV
PI 14 F 33 0.04 17.54 2.86 1.95 3.78 I
PI 1 F 34 0.05 3.98 1.38 0.34 2.43 II
PS 12b F 34 0.18 0.54 −0.61 −2.02 0.80 I
PS 5 F 35 0.15 2.09 0.74 0.04 1.44 III
PS 14 F 35 0.36 0.41 −0.89 −1.89 0.11 IV
PS 21 M 26 0.37 1.21 0.19 −0.64 1.02 IV
PS 22 M 27 0.31 0.15 −1.89 −3.86 0.08 I
PI 40 M 28 0.09 1.93 0.66 −1.33 2.65 I
PS 30 M 29 0.25 1.84 0.61 −0.04 1.26 I
PI 28 M 31 0.02 1.16 0.15 −1.88 2.18 II
PS 23 M 31 0.31 0.37 −0.98 −2.38 0.41 IV
PS 26b M 31 0.48 0.31 −1.17 −2.32 −0.02 I
PS 29 M 31 0.46 0.76 −0.28 −1.09 0.54 II
PI 8 M 32 0.17 0.91 −0.09 −1.10 0.92 II
PI 18 M 32 0.11 2.26 0.82 −0.10 1.74 II
PI 43 M 32 0.11 1.58 0.46 −1.52 2.44 I
PS 18 M 32 0.16 0.49 −0.71 −1.87 0.44 II
PS 19 M 32 0.32 0.57 −0.56 −1.32 0.21 I
MFS 104 M 33 0.49 0.36 −1.03 −2.18 0.11 I
PI 2 M 33 0.09 1.93 0.66 −0.76 2.08 IV
PI 12 M 33 0.17 1.54 0.43 −0.75 1.61 I
PI 34 M 33 0.15 0.77 −0.26 −2.23 1.72 II
PI 44 M 33 0.14 1.42 0.35 −0.66 1.36 IV
PI 46 M 33 0.23 0.25 −1.38 −3.35 0.59 II
PS 6 M 33 0.18 0.39 −0.95 −2.92 1.02 I
PS 10 M 33 0.07 0.52 −0.66 −2.08 0.77 II
PI 6 M 34 0.02 3.48 1.25 −0.25 2.74 I
PI 7 M 34 0.04 1.34 0.29 −1.18 1.76 I
PS 16 M 34 0.10 1.92 0.65 −0.07 1.37 IV
PS 20 M 34 0.25 0.42 −0.87 −2.27 0.53 I
MFS 7 M 35 0.68 0.57 −0.56 −1.56 0.43 IV
PI 10 M 35 0.08 2.18 0.78 −0.65 2.21 I
PI 20 M 35 0.11 0.79 −0.24 −2.21 1.74 I
PS 2 M 35 0.19 0.26 −1.34 −3.31 0.63 I
PS 7 M 35 0.44 0.37 −1.00 −1.47 −0.54 I
PS 13 M 35 0.25 0.11 −2.18 −4.15 −0.21 I
PS 15 M 35 0.38 0.57 −0.56 −1.45 0.34 II
Full-term newborns
MFS 61a F 36 0.45 0.32 −1.14 −2.08 −0.20 IV
PS 32 F 36 0.07 2.69 0.99 0.08 1.89 II
MFS 66 F 37 0.25 0.70 −0.36 −2.33 1.61 IV
MFS 77 F 38 0.10 0.87 −0.14 −1.56 1.28 I
MFS 94 F 38 0.47 0.14 −1.97 −3.38 0.56 IV
MFS 111 F 38 0.36 1.30 0.26 −0.88 1.41 II
MFS 8 F 39 0.57 0.50 −0.69 −1.58 0.20 I
MFS 29 F 39 0.29 0.40 −0.92 −2.89 1.06 II
MFS 78 F 39 0.29 0.60 −0.51 −2.06 1.04 IV
MFS 85 F 39 0.35 0.66 −0.42 −1.31 0.48 III
MFS 105 F 39 0.18 0.18 −1.71 −3.69 0.26 III
MFS 6 F 40 0.59 0.29 −1.24 −2.38 −0.10 II
MFS 15 F 40 0.20 0.24 −1.43 −2.83 −0.03 I
MFS 24 F 40 0.22 0.79 −0.24 −1.14 0.66 IV
MFS 41 F 40 0.36 0.10 −2.30 −4.27 −0.33 I
MFS 53 F 40 0.25 0.56 −0.58 −1.98 0.82 III
MFS 54 F 40 0.15 0.71 −0.34 −1.37 0.69 III
MFS 73 F 40 0.07 1.81 0.59 −0.83 2.02 II
MFS 79 F 40 0.20 0.58 −0.54 −1.70 0.61 IV
MFS 108 F 40 0.06 1.16 0.15 −1.84 2.14 I
MFS 63 F 40 0.32 0.54 −0.62 −1.76 0.53 I
MFS 9 F 41 0.58 0.10 −2.30 −4.27 −0.33 IV
MFS 11 F 41 0.48 1.20 0.18 −0.46 0.82 II
MFS 26 F 41 0.22 0.95 −0.05 −1.20 1.10 I
MFS 42 F 42 0.16 0.18 −1.71 −3.83 0.40 II
MFS 62 F 42 0.33 0.47 −0.76 −2.15 0.64 II
PS 24 M 36 0.68 0.82 −0.19 −0.72 0.33 III
MFS 74 M 36 0.61 0.87 −0.14 −1.28 1.00 II
MFS 61b M 36 0.50 0.23 −1.47 −2.87 −0.07 IV
MFS 31 M 37 0.04 0.96 −0.04 −2.07 1.98 III
MFS 36 M 37 0.60 0.47 −0.76 −1.47 −0.04 I
MFS 16 M 38 0.33 1.06 0.06 −1.09 1.20 I
MFS 27 M 38 0.22 0.23 −1.47 −2.62 −0.32 I
MFS 45 M 38 0.13 0.67 −0.40 −2.38 1.58 I
MFS 103 M 38 0.27 0.24 −1.43 −2.58 −0.28 IV
MFS 65 M 38 0.15 6.37 1.85 1.34 2.36 IV
MFS 82 M 38 0.18 0.64 −0.45 −1.60 0.071 II
MFS 1 M 39 0.30 1.16 0.15 −0.85 1.15 IV
MFS 5 M 39 0.19 1.80 0.59 −0.42 1.60 III
MFS 30 M 39 0.09 3.60 1.28 0.25 2.31 IV
MFS 43 M 39 0.43 0.47 −0.76 −1.51 0.00 IV
MFS 58 M 39 0.36 0.58 −0.54 −1.37 0.28 III
MFS 59 M 39 0.17 0.85 −0.16 −1.07 0.75 IV
MFS 64 M 39 0.13 2.93 1.26 0.23 1.92 IV
MFS 71 M 39 0.20 0.75 −0.29 −1.06 0.49 II
MFS 72 M 39 0.47 0.85 −0.16 −0.88 0.55 III
MFS 87 M 39 0.47 0.45 −0.80 −1.94 0.35 I
MFS 95 M 39 0.43 0.88 −0.13 −0.89 0.63 IV
MFS 99 M 39 0.23 0.43 −0.84 −2.81 1.13 II
MFS 2 M 40 0.75 1.22 0.20 −0.37 0.77 IV
MFS 25 M 40 0.20 0.87 −0.14 −1.29 1.01 I
MFS 39 M 40 0.69 0.13 −2.04 −3.44 −0.64 I
MFS 40 M 40 0.42 0.55 −0.60 −1.49 0.30 IV
MFS 44 M 40 0.24 0.16 −1.83 −3.81 0.14 I
MFS 56 M 40 0.14 1.56 0.44 −0.47 1.36 I
MFS 60 M 40 0.13 0.45 −0.80 −2.21 0.61 I
MFS 84 M 40 0.61 0.35 −1.05 −2.05 −0.05 I
MFS 97 M 40 0.50 0.14 −1.97 −3.36 −0.57 II
MFS 57 M 41 0.09 2.77 1.02 0.09 1.95 IV
MFS 68 M 41 0.40 0.64 −0.45 −1.21 0.32 IV
MFS 75 M 41 0.31 1.61 0.48 −0.42 1.37 IV
MFS 86 M 41 0.42 1.11 0.10 −0.54 0.75 I
MFS 88 M 42 0.45 1.21 0.19 −0.57 0.95 I
*

Group I, preterm newborns whose mothers had no history of active or passive cigarette exposure during the pregnancy; group II, preterm newborns whose mothers actively smoked cigarettes throughout the pregnancy; group III, preterm newborns whose mothers actively smoked cigarettes during first trimester only; and group IV, preterm newborns whose mothers were exposed only to passive cigarette smoke.